6 ms·

I am confident the OP meant “meet God” as short-hand for “a spiritual and transcendental experience wherein the ego is destroyed and rebuilt anew with a profoun

I am confident the OP meant “meet God” as short-hand for “a spiritual and transcendental experience wherein the ego is destroyed and rebuilt anew with a profoundly different perspective”. I don’t think anyone would earnestly claim that there is zero risk to any hallucinogenic experience. One of my hopes is that through study we can better understand the ingredients that lead to profoundly positive experiences vs. profoundly traumatizing experiences. And anyone who claims we know that today is acting in bad faith.

ipnon 4y ago
Roland Griffiths’ foundational psilocybin study did not have any adverse outcomes. They used a simple protocol: no patient or patient family history of schizophrenia or bipolar, patients underwent cognitive behavioral therapy before and after the trial, patients were made to develop a warm and trusting rapport with the physicians before administration, and a physician was on hand for the duration of the psilocybin administration to coach the patient through unforeseen disturbances and administer anxiolytics in the case of panic attacks. With this simple protocol they reported no adverse affects, although they also did not report a 100% rate of efficacy. Griffiths wrote an entire separate study on this protocol, it is self-recommending.
- PraetorianGourd 4y ago
  This one? https://pubmed.ncbi.nlm.nih.gov/27909165/ https://pubmed.ncbi.nlm.nih.gov/27909165/ Terminal cancer patients, those expecting to die and “meet God” soon, are a very, very niche audience compared to a general population with non-specific major depressive disorders. But at the same time, I love this. The more study, the better!
  - ipnon 4y ago
    After seeing the responses to my original post I wish I had used different terms. I did not mean "meeting God" literally, but used it more as a metaphor for "meeting your maker": coming to terms with universal human problems like mortality, our relations to our friends and family, the nature of good and evil, things of that nature. "Meeting God" I thought would sum all this up poetically, but you can always count on HN to take things literally! Griffiths' research is all high quality. He is the pioneer in making this field of scientific research palatable to the mainstream medical establishment.

ipnon 4y ago

Roland Griffiths’ foundational psilocybin study did not have any adverse outcomes. They used a simple protocol: no patient or patient family history of schizophrenia or bipolar, patients underwent cognitive behavioral therapy before and after the trial, patients were made to develop a warm and trusting rapport with the physicians before administration, and a physician was on hand for the duration of the psilocybin administration to coach the patient through unforeseen disturbances and administer anxiolytics in the case of panic attacks. With this simple protocol they reported no adverse affects, although they also did not report a 100% rate of efficacy. Griffiths wrote an entire separate study on this protocol, it is self-recommending.

PraetorianGourd 4y ago
This one? https://pubmed.ncbi.nlm.nih.gov/27909165/ https://pubmed.ncbi.nlm.nih.gov/27909165/ Terminal cancer patients, those expecting to die and “meet God” soon, are a very, very niche audience compared to a general population with non-specific major depressive disorders. But at the same time, I love this. The more study, the better!
- ipnon 4y ago
  After seeing the responses to my original post I wish I had used different terms. I did not mean "meeting God" literally, but used it more as a metaphor for "meeting your maker": coming to terms with universal human problems like mortality, our relations to our friends and family, the nature of good and evil, things of that nature. "Meeting God" I thought would sum all this up poetically, but you can always count on HN to take things literally! Griffiths' research is all high quality. He is the pioneer in making this field of scientific research palatable to the mainstream medical establishment.